Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2017 02:00 ET | Source: Mendus AB

Immunicum AB Meddelar att Första Patienten Rekryterats i Fas I/II GIST-studien efter Tillägg i Studieprotokollet

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GÖTEBORG den 7 mars 2017 - Immunicum AB...
March 07, 2017 02:00 ET | Source: Mendus AB

Immunicum AB Announces Enrollment of First Patient in Phase I/II GIST Trial Following Study Protocol Amendment

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GOTHENBURG, Sweden, March 7, 2017 -...
March 02, 2017 02:00 ET | Source: Mendus AB

Immunicum rekryterar Sijme Zeilemaker som Senior Director Business Development

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GÖTEBORG den 2 mars 2017 - Immunicum AB...
March 02, 2017 02:00 ET | Source: Mendus AB

Immunicum AB Appoints Sijme Zeilemaker as Senior Director Business Development

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GOTHENBURG, Sweden, March 2, 2017 -...
March 01, 2017 02:00 ET | Source: Mendus AB

Immunicum AB presenterar och deltar i ett flertal konferenser i mars

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GÖTEBORG den 1 mars 2017 - Immunicum AB...
March 01, 2017 02:00 ET | Source: Mendus AB

Immunicum AB Announces Presentations and Participations at Upcoming Conferences in March

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GOTHENBURG, Sweden, March 1, 2017 -...
February 17, 2017 01:30 ET | Source: Mendus AB

Immunicum AB: Bokslutskommuniké 2016 (juli 2016 - december 2016)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GÖTEBORG den 17 februari 2017 -...
February 17, 2017 01:30 ET | Source: Mendus AB

Immunicum AB: Year-End Report 2016 (July 2016 - December 2016)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GOTHENBURG, Sweden, February 17,...
February 14, 2017 11:40 ET | Source: Mendus AB

Immunicum AB announces approval in France for its Clinical Trial Application for INTUVAX in metastatic renal cell carcinoma

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GOTHENBURG, Sweden, February 14, 2017 -...
February 14, 2017 11:40 ET | Source: Mendus AB

Immunicum AB har erhållit godkännande i Frankrike för sin kliniska prövningsansökan för INTUVAX i metastaserade njurcancer

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GÖTEBORG den 14 februari 2017 - Immunicum...